Mergers & Acquisitions ·
Aurora Cannabis receives alternative proposal from Organigram Global Inc. for its acquisition
CURLDCuraleaf Holdings, Inc.
Curaleaf Holdings, Inc. issued a statement acknowledging that Aurora Cannabis Inc. received an alternative transaction proposal from Organigram Global Inc. Curaleaf maintains that its enhanced premium bid of October 6, 2026 to purchase all outstanding common shares of Aurora remains outstanding and represents better value with greater certainty and speed to close. The company criticized the lack of material details in the competing offer, including break fees and investor rights granted to BAT, and accused Aurora's board of fiduciary dereliction for denying Curaleaf due diligence access. This development introduces a competing bid scenario that could alter the terms or outcome of the pending acquisition. Curaleaf is a leading international provider of consumer and medical cannabis products.